New test for breast cancer
1 November 2017
From 1 November 2017, thousands of Australian patients and their families will be able to access new Medicare supported treatments for breast and ovarian cancer, heart disease, epilepsy, stroke, lymphoma and liver tumours.
Women with a family history of breast and ovarian cancer will be supported through a new genetic testing through the BRCA 1 and 2 genetic tests. The new Medicare services will be available to women who are diagnosed with breast or ovarian cancer, following an assessment by a medical specialist. If they are found to have the mutations, their close relatives will also be eligible for testing through Medicare.
For more information please visit The Hon Greg Hunt MP website.